Physician profile
Anand V Palagiri
NPI 1578769006
$18,393.74
in general payments reported to CMS, 2019-2025
9 companies · $1,560 in 2025
The $1,560 reported for 2025 was more than what 94% of Pediatric Urology providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $383 · 2020: $360 · 2021: $370 · 2022: $9,158 · 2023: $5,770 · 2024: $793 · 2025: $1,560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,400 · Food and Beverage: $2,109 · Travel and Lodging: $614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,400.00 |
| Food and Beverage | $2,108.98 |
| Travel and Lodging | $613.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Palette Life Sciences, INC. | $15,683.52 | 2019-2023 | |
| Teleflex LLC | $2,236.55 | 2024-2025 | Deflux Metal Needle, Deflux, Barrigel |
| Karl Storz Endoscopy-America | $151.61 | 2023-2024 | Hopkins, N.A. |
| Cook Medical LLC | $133.49 | 2019 | |
| Rochester Medical Corporation | $57.33 | 2022 | |
| Convatec INC. | $51.38 | 2019-2025 | |
| Novo Nordisk INC | $41.09 | 2024 | |
| Alnylam Pharmaceuticals INC. | $20.07 | 2019 | |
| Merck Sharp & Dohme LLC | $18.70 | 2025 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anand Palagiri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.